Things are starting to move.
There have been individual investments in some small‑scale biotechnologies or pharmaceuticals. We've started to see the benefits. In Quebec City, Medicago is now conducting its phase 3 clinical trials. Other technologies have also received financial support in British Columbia and Alberta, for example.
However, much more investment is needed. I estimate that the Canadian Institutes of Health Research, or CIHR, budget for basic research should be doubled over the next 10 years.